BioConsortia Stock

BioConsortia is developing highly effective microbial consortia for increasing agricultural yields.

Sign up today and learn more about BioConsortia Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About BioConsortia Stock

BioConsortia is developing highly effective microbial consortia for increasing agricultural yields. Soil and plant associated microbes interact with and supplement the functions encoded by the crop genome. Opportunities abound to exploit these plant-microbe interactions but overwhelming complexity and the huge amount of genetic diversity has hindered the realization of these by conventional R&D methods. BioConsortia has developed a revolutionary Advanced Microbial Selection (AMS) process for crop trait enhancement that uses iterative rounds of plant phenotyping and selection to co-select for beneficial changes in the microbiome. Isolates are obtained from the microbiome of plants expressing the desired traits and are developed as consortia for application as commercial seed treatment, drench or granule products. We have a pipeline of products for increased fertilizer utilization, growth improvement and other beneficial crop traits, such as abiotic tolerance and enhanced metabolite expression.

Funding History

April 2014$15.0M
November 2016$4.0M
November 2016$8.0M
March 2018$10.0M

Management

Board of Directors

Andrew Chung

Senior Vice President, Operations & Administration

Christina Huben

CEO

Marcus Meadows-Smith

SVP, Business Development & Strategy

Joe Schmidt

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo